| Toxicity of silver nanoparticles in biological systems: Does the complexity of biological systems matter? R Vazquez-Muñoz, B Borrego, K Juárez-Moreno, M García-García, ... Toxicology Letters 276, 11-20, 2017 | 246 | 2017 |
| New observations on antigenic diversification of RNA viruses. Antigenic variation is not dependent on immune selection E Domingo, J Díez, MA Martínez, J Hernández, A Holguín, B Borrego, ... Journal of general virology 75, 949-949, 1994 | 178 | 1994 |
| Potential Application Of Silver Nanoparticles To Control The Infectivity Of Rift Valley Fever Virus In Vitro And In Vivo B Borrego, G Lorenzo, JD Mota-Morales, H Almanza-Reyes, F Mateos, ... Nanomedicine: Nanotechnology, Biology and Medicine, 2016 | 147 | 2016 |
| Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection. B Borrego, IS Novella, E Giralt, D Andreu, E Domingo Journal of virology 67 (10), 6071-6079, 1993 | 146 | 1993 |
| Enhancing DNA immunization by targeting ASFV antigens to SLA-II bearing cells JM Argilaguet, E Perez-Martin, C Gallardo, FJ Salguero, B Borrego, ... Vaccine 29 (33), 5379-5385, 2011 | 104 | 2011 |
| Current strategies for subunit and genetic viral veterinary vaccine development A Brun, J Bárcena, E Blanco, B Borrego, D Dory, JM Escribano, ... Virus Research 157 (1), 1-12, 2011 | 101 | 2011 |
| Recent advances in the development of recombinant vaccines against classical swine fever virus: Cellular responses also play a role in protection L Ganges, JI Núñez, F Sobrino, B Borrego, N Fernández-Borges, ... The Veterinary Journal 177 (2), 169-177, 2008 | 79 | 2008 |
| Evaluation of silver nanoparticles for the prevention of SARS-CoV-2 infection in health workers: in vitro and in vivo H Almanza-Reyes, S Moreno, I Plascencia-López, M Alvarado-Vera, ... medRxiv, 2021 | 76 | 2021 |
| DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses B Borrego, P Fernandez-Pacheco, L Ganges, N Domenech, ... Vaccine 24 (18), 3889-3899, 2006 | 62 | 2006 |
| A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection E López-Gil, G Lorenzo, E Hevia, B Borrego, M Eiden, M Groschup, ... PLoS Negl Trop Dis 7 (7), e2309, 2013 | 57 | 2013 |
| Attenuated foot-and-mouth disease virus RNA carrying a deletion in the 3′ noncoding region can elicit immunity in swine MR Pulido, F Sobrino, B Borrego, M Sáiz Journal of virology 83 (8), 3475-3485, 2009 | 47 | 2009 |
| RNA structural domains in noncoding regions of the foot-and-mouth disease virus genome trigger innate immunity in porcine cells and mice M Rodríguez-Pulido, B Borrego, F Sobrino, M Sáiz Journal of virology 85 (13), 6492-6501, 2011 | 44 | 2011 |
| Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunization R Martín-Folgar, G Lorenzo, H Boshra, J Iglesias, F Mateos, B Borrego, ... MAbs 2 (3), 275-284, 2010 | 40 | 2010 |
| Use of substituted and tandem-repeated peptides to probe the relevance of the highly conserved RGD tripeptide in the immune response against foot-and-mouth disease virus IS Novella, B Borrego, MG Mateu, E Domingo, E Giralt, D Andreu FEBS letters 330 (3), 253-259, 1993 | 37 | 1993 |
| Characterization of neutralization sites on the circulating variant of swine vesicular disease virus (SVDV): a new site is shared by SVDV and the related coxsackie B5 virus B Borrego, E Carra, JA Garcı́a-Ranea, E Brocchi Journal of general virology 83 (1), 35-44, 2002 | 36 | 2002 |
| Lethal mutagenesis of Rift Valley fever virus induced by favipiravir B Borrego, AI de Ávila, E Domingo, A Brun Antimicrobial agents and chemotherapy 63 (8), 2019 | 34 | 2019 |
| A DNA vaccine encoding foot-and-mouth disease virus B and T-cell epitopes targeted to class II swine leukocyte antigens protects pigs against viral challenge B Borrego, JM Argilaguet, E Pérez-Martín, J Dominguez, ... Antiviral research 92 (2), 359-363, 2011 | 34 | 2011 |
| DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/c mice AM Barfoed, F Rodriguez, D Therrien, B Borrego, F Sobrino, S Kamstrup Antiviral research 72 (3), 178-189, 2006 | 34 | 2006 |
| Subcellular distribution of swine vesicular disease virus proteins and alterations induced in infected cells: a comparative study with foot-and-mouth disease virus and … MA Martín-Acebes, M González-Magaldi, MF Rosas, B Borrego, E Brocchi, ... Virology 374 (2), 432-443, 2008 | 29 | 2008 |
| Adaptability costs in immune escape variants of vesicular stomatitis virus IS Novella, DL Gilbertson, B Borrego, E Domingo, JJ Holland Virus research 107 (1), 27-34, 2005 | 26 | 2005 |
